65% Of U.S. Cancer Patients Survive At Least 5 Years

162017_132140396847214_292624_nA recent analysis by the U.S. Centers for Disease Control and Prevention (CDC) found the 65% of patients in the United States who have cancer survive at least five years after diagnosis. National health goals in the United States include a goal of 71.1% for 5-year cancer survival rates after initial diagnosis.

The CDC analysis involved national data from population-based cancer registries in the U.S. for 2011. The 2011 annual incidence of cancer was 451 per 100,000 people, which means that approximately 1,500,000 invasive cancers were diagnosed in 2011. Almost one-half of the cancers were prostate, female breast, lung and bronchus, and colon and rectum: the five-year survival rate for prostate cancer was 97%; the five-year survival rate for female breast cancer was 88%, the five-year survival rate for cervix uteri cancer was 68%, the five-year survival rate for colorectal cancer was 63% (63% for men, 64% for women), and the five-year survival rate for lung cancer was 18% (15% for men, 21% for women).

Five-Year Cancer Survival Rates By Age Group

The five-year cancer survival rate for the 44 and younger age group was 81% (76% for men, 84% for women); the five-year cancer survival rate for the 45 to 54 age group was 71% (66% for men, 76% for women); the five-year cancer survival rate for the 55 to 64 age group was 68% (68% for men, 69% for women); the five-year cancer survival rate for the 65 to 74 age group was 64% (67% for men, 60% for women); and, the five-year cancer survival rate for those 75 and older was 52% (55% for men, 49% for women).

The CDC’s analysis found that men have a higher overall cancer rate than women although both men and women had the same cancer survival rate (65%) after five years.

Blacks had the highest incidence of cancer and also had the lowest five-year survival rate (60%).

There were 13.7 million cancer survivors in the United States in 2012.

Source

Statistics Regarding Misdiagnosis Of Cancer Cases

The world-renowned Johns Hopkins Hospital conducted a review of tissue samples from 6,000 cancer patients throughout the United States. The Johns Hopkins’ researchers determined that one in every 71 cases was misdiagnosed, such as a biopsy marked as cancerous that was not cancer, and as many as one-in-five cancer cases was misclassified.

Source

When patients who have cancer are misdiagnosed as being cancer-free and then later find out that they had cancer that may now be untreatable or requires more intensive or invasive treatment, those patients, and their families, are devastated by the harm caused by the misdiagnosis.

And when patients who are erroneously told that they have cancer and then later are determined to have been cancer-free, they, and their families, are seriously harmed by the physical and emotional toll of “living with cancer” that did not exist, which may have involved unnecessary and harmful cancer treatments.

Both situations may involve medical negligence for which the victims of cancer misdiagnosis may seek compensation for their substantial injuries, losses, and damages.

If you or a loved one were injured as a result of the misdiagnosis of cancer in the United States, you should promptly consult with a local medical malpractice attorney in your state who may investigate your cancer misdiagnosis claim for you and represent you in a cancer medical malpractice case, if appropriate.

Visit our website to submit a short, secure form, or call us toll-free in the United States at 800-295-3959, to be connected with medical malpractice lawyers in your U.S. state who may assist you.

Turn to us when you don’t know where to turn.

You can follow us on FacebookTwitterGoogle+, and LinkedIn as well.

This entry was posted on Friday, May 15th, 2015 at 5:32 am. Both comments and pings are currently closed.

placeholder

Easy Free Consultation

Fill out the form below for a free consultation or contact us directly at 800.295.3959

Easy Free Consultation

Fill out the form below for a free consultation or contact us directly at 800.295.3959